Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy

Authors
Wang, Xin
McIntosh, Lacey J
Selove, William
Zivny, Jaroslav
Cerny, Jan
UMass Chan Affiliations
Division of Hematology Oncology, Department of Medicine
Division of Gastroenterology, Department of Medicine
Department of Pathology
Division of Oncologic Imaging, Department of Radiology
Department of Medicine
Document Type
Letter to the Editor
Publication Date
2021-03-15
Keywords
Hematology
Hemic and Lymphatic Diseases
Neoplasms
Oncology
Radiology

Metadata
Show full item record
Link to Full Text
https://doi.org/10.1080/10428194.2021.1894646
Abstract
Our case highlights the importance of recognizing the atypical radiological response of patients with hematological malignancies treated with polatuzumab vedotin or other antibody-drug conjugates.
Source

Wang X, McIntosh L, Selove WJ, Zivny J, Cerny J. Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy. Leuk Lymphoma. 2021 Mar 15:1-4. doi: 10.1080/10428194.2021.1894646. Epub ahead of print. PMID: 33719894. Link to article on publisher's site
DOI
10.1080/10428194.2021.1894646
Permanent Link to this Item
http://hdl.handle.net/20.500.14038/48511
PubMed ID
33719894
Related Resources

Link to Article in PubMed
Collections